If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPEMV.L Regulatory News (PEMV)

  • There is currently no data for PEMV

Quarterly Report

3 Mar 2015 16:17

RNS Number : 4401G
Pembroke VCT PLC
03 March 2015
 

3 March 2015

 

 

PEMBROKE VCT PLC

 

Quarterly Report

for the period from 1 October to 31 December 2014

 

Pembroke VCT plc (the "Company") presents its quarterly report for the period from 1 October to 31 December 2014.

 

· £2.9 million invested in the quarter to 31 December

· £15.8 million committed with £15.1 million invested to date

· New B Ordinary Share offer launched

 

This interim management statement contains information that covers the period up to the date of its publication.

 

Performance

 

The net asset value of the Company at 31 December 2014 was £17.8 million, broadly in line with the half-year report. In total, an additional £2.9 million was invested in the quarter in follow-on investments into the existing portfolio and into two new investments. Investments are held at fair value, with all but four still held at cost. No further revaluations have taken place since the half-yearly report was published in November 2014.

 

Investments made in the period

 

In the quarter ended 31 December 2014, the Company invested a total of £2.9 million comprising follow-on investments in seven portfolio companies amounting to £1.3 million and £1.6 million in two new investments.

 

Follow-on investments in the quarter ended 31 December 2014:

 

· Boom Cycle: Investment of £22,250 in new equity as part of the original committed capital

· Chucs Limited: Investment of £200,000 in new loan notes

· Bella Freud: Investment of £50,000 in new loan notes as part of the original committed capital

· Premium fast-food restaurant chain: Investment of £694,400 in loan notes as part of the original committed capital

· Penfield: Investment of £250,000 in new loan notes as part of the original committed capital

· Dilly & Wolf (formerly B Healthy Snacks): Investment of £50,000 in new loan notes as part of the original committed capital

· Bella Freud Perfume: Investment of £50,000 in new loan notes as part of the original committed capital

 

New investments in the quarter ended 31 December 2014:

 

· BLAZE: Commitment of £490,000, of which £100,000 was invested in new equity in the period (Media & Technology sector)

BLAZE, founded in 2012, designs, develops and manufactures hardware products which can predominantly be used in bicycles, using innovative technology and high quality materials. BLAZE's first product is the world's first laserlight, re-designing the classic bicycle light. The Company has invested £100,000 in the form of new ordinary equity, principally to fund ongoing working capital and the development of new products.

 

· Stillking Films: Commitment of $2,320,220 (£1,451,770), all of which was invested in new equity in the period (Media & Technology sector)

Stillking Films is a prolific producer of commercials, TV series, feature films and music videos. The company has created commercials for almost all Dow Jones and FTSE advertisers. They have co-produced a number of successful feature films including Casino Royale, Narnia, Mission Impossible 4 and The Bourne Identity and created music videos for artists including Beyoncé, Kanye West, Blur, Madonna and One Direction. The Company has invested $2,320,220 in the form of new equity, principally to grow the business through potential acquisition opportunities.

 

Investments made post-period end

 

Post the period end, the Company invested a total of £0.4m in follow on investments. These investments comprised:

 

· Plenish: Investment of £50,000 in new loan notes

· Chucs Bar & Grill: Investment of £130,000 in new loan notes

· Boom Cycle: Investment of £22,250 in new equity as part of the original committed amount

· Kat Maconie: Investment of £100,000 in new loan notes

· BLAZE: Investment of £100,000 in new equity as part of the original committed amount

 

New B Ordinary Share Offer

 

Following the success of its first offer of Ordinary Shares, the Company launched a new B Ordinary Share offer in October 2014. The B Ordinary Shares are a separate class of share, distinct from the existing Ordinary Shares, and with distinct rights to a separate pool of assets and liabilities.

 

The B Ordinary share offer has been positively received by the VCT market, with the Company receiving subscriptions and interest from existing shareholders and new investors alike. The Company has built a solid pipeline of new investments which are currently undergoing due diligence.

 

About the Company

 

Pembroke VCT plc (the "Company") is a generalist VCT focused on private equity style investments in the leisure and premium brands sectors. The Company seeks to invest in a diversified portfolio of small, principally unquoted companies, selecting those which Oakley Investment Managers LLP believes provide the opportunity for value appreciation.

 

The Company is not aware of any significant event or transaction which has occurred between 1 October 2014 and 27 February 2015 which has had a material effect on the financial position of the Company and has not been detailed above.

 

 

 

For further details about the Company please either visit the Company's website,

 

Pembroke VCT plc

www.pembrokevct.com,

 

or contact:

 

Oakley Investment Managers LLP (Manager)

+44 20 7766 6900

Peter Dubens / Andrew Wolfson

 

The City Partnership (UK) Limited (Company Secretary)

0131 243 7210

Doreen Nic

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKNDDABKDQNK
Date   Source Headline
31st Oct 20182:37 pmRNSIssue of Equity
11th Oct 20183:49 pmRNSReplacement: Issue of Equity
1st Oct 20189:43 amRNSTotal Voting Rights
28th Sep 20184:03 pmRNSDirector/PDMR Shareholding
28th Sep 20184:01 pmRNSIssue of Equity
27th Sep 20184:41 pmRNSResults of General Meeting
27th Sep 20184:32 pmRNSResult of AGM
10th Sep 20189:54 amRNSNet Asset Value(s)
29th Aug 20183:24 pmRNSPublication of a Prospectus and Circular
28th Aug 20185:00 pmRNSDirectorate Change
1st Aug 20181:50 pmRNSIntention to launch an Offer for Subscription
20th Jul 20187:59 amRNSAnnual Financial Report
2nd Jul 20183:16 pmRNSIssue of Equity
1st May 20188:12 amRNSTotal Voting Rights
6th Apr 20184:27 pmRNSDirector/PDMR Shareholding
6th Apr 20184:25 pmRNSIssue of Equity
3rd Apr 20189:48 amRNSTotal Voting Rights
9th Mar 20181:51 pmRNSIssue of Equity
28th Feb 20185:12 pmRNSNet Asset Value(s)
1st Feb 20184:19 pmRNSTransaction in Own Shares
11th Jan 20182:02 pmRNSExtension of Early Application Deadline
8th Jan 201811:19 amRNSResult of General Meeting
1st Dec 20174:30 pmRNSPublication of Prospectus and Circular
1st Nov 20178:42 amRNSTotal Voting Rights
27th Oct 20175:01 pmRNSHalf-year Report
26th Oct 20173:54 pmRNSIssue of Equity
19th Sep 20173:45 pmRNSNew share offer
8th Sep 20179:45 amRNSResult of AGM
8th Sep 20179:43 amRNSQuarterly Report
3rd Aug 201710:32 amRNSDividend Declaration
1st Aug 20179:51 amRNSTotal Voting Rights
31st Jul 20173:59 pmRNSAnnual Financial Report
7th Jul 201712:00 pmRNSIssue of Equity
3rd Jul 20178:24 amRNSTotal Voting Rights
8th Jun 201710:52 amRNSIssue of Equity
1st Jun 20179:59 amRNSTotal Voting Rights
4th May 20179:39 amRNSIssue of Equity
2nd May 201710:23 amRNSTotal Voting Rights
25th Apr 201710:45 amRNSExtension of Offer Closing Date
11th Apr 20171:40 pmRNSTR1 Notification of major interests in shares
6th Apr 20175:17 pmRNSDirector/PDMR Shareholding
6th Apr 20175:02 pmRNSIssue of Equity
30th Mar 20174:59 pmRNSRelated Party Transaction
21st Mar 20172:14 pmRNSDividend Declaration
1st Mar 20179:58 amRNSTotal Voting Rights
13th Feb 20171:23 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Feb 201710:10 amRNSIssue of Equity
1st Feb 20175:42 pmRNSQuarterly Report
5th Jan 201710:47 amRNSResult of general meeting
30th Nov 20165:36 pmRNSPublication of Prospectus and Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.